JOVANA
Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

Cytotoxic Chemotherapy: Hitting Cell Division

The first generation of cancer drugs — alkylating agents, antimetabolites, and topoisomerase poisons — that attack the cell as it copies and splits.

One blunt idea, many weapons

Cytotoxic chemotherapy rests on a single bet: a tumour divides faster than most of you, so a poison that wrecks cell division will hurt the cancer disproportionately. This is a bet on *rate*, not on identity, which is why the selectivity is so rough. Yet for decades these drugs were all we had, and many remain backbone therapy today — cheap, fast-acting, and often curative in cancers like testicular cancer and some leukaemias and lymphomas.

The common thread is DNA. A cell about to divide must first copy its entire genome, and that copying is a moment of profound vulnerability. Damage the DNA badly enough, or starve the cell of the parts it needs to copy it, and the cell either stalls or trips its apoptosis alarm and dies. The three classic families below each attack that copying step in a different way.

Three classic families

  1. Alkylating agents glue a small carbon group onto DNA bases. These covalent scars cross-link the two DNA strands so they cannot pull apart to be copied. Cisplatin (a platinum drug that behaves the same way) and cyclophosphamide are famous examples — brutal but effective.
  2. Antimetabolites are decoys. They mimic the natural building blocks the cell needs to make DNA — bases, folate, sugars — and either get mistakenly built into the growing strand or jam the enzymes that make those building blocks. Methotrexate and 5-fluorouracil starve the cell of raw material.
  3. Topoisomerase inhibitors sabotage the enzymes that untangle DNA. To copy a twisted double helix, the cell must cut, swivel, and reseal it; topoisomerase poisons freeze that process mid-cut, leaving lethal breaks. Doxorubicin and irinotecan work here.
A dividing cell, and where each drug strikes
=============================================
  building blocks  ──►  DNA copied  ──►  strands separate  ──►  cell splits
        ▲                   ▲                  ▲
        │                   │                  │
  antimetabolites     topoisomerase       alkylating agents
  (starve the         inhibitors          (cross-link the
   supply line)       (freeze the          two strands so
                       untangling)         they cannot part)

Different steps, one outcome: copying fails → damage piles up → apoptosis.
Each cytotoxic family jams a different stage of DNA replication, but all funnel the cell toward the same self-destruct.

Why the side effects, and why it still matters

Because these drugs only distinguish cells by how fast they divide, the healthy tissues that also divide quickly pay the bill. Bone marrow stops making blood cells, the gut lining sheds, hair falls out. This is the signature of a poor therapeutic index — the gap between an effective dose and a toxic one is thin, so oncologists dose right up to the edge of tolerability.